Disclosed are nutritional emulsions comprising fat, carbohydrate, protein, and calcium HMB, wherein the nutritional emulsion has a weight ratio of a soluble calcium binding capacity to soluble calcium of from about 2.3 to about 12.0. Also disclosed are nutritional emulsions comprising fat, carbohydr
Disclosed are nutritional emulsions comprising fat, carbohydrate, protein, and calcium HMB, wherein the nutritional emulsion has a weight ratio of a soluble calcium binding capacity to soluble calcium of from about 2.3 to about 12.0. Also disclosed are nutritional emulsions comprising fat, carbohydrate, protein, and calcium HMB, wherein the nutritional emulsion comprises less than 900 mg/L of soluble calcium in a weight ratio of calcium HMB to soluble calcium of from 6:1 to 15:1. The nutritional emulsions are surprisingly stable and generate minimal or no bitter flavors or after taste over time.
대표청구항▼
1. A shelf stable nutritional emulsion comprising protein, carbohydrate, fat, and from about 0.1% to about 10% of calcium HMB by weight of the nutritional emulsion, wherein the nutritional emulsion comprises at least one of a soluble citrate, a soluble phosphate, and a soluble protein, such that: i)
1. A shelf stable nutritional emulsion comprising protein, carbohydrate, fat, and from about 0.1% to about 10% of calcium HMB by weight of the nutritional emulsion, wherein the nutritional emulsion comprises at least one of a soluble citrate, a soluble phosphate, and a soluble protein, such that: i) the nutritional emulsion has a weight ratio of a soluble calcium binding capacity to soluble calcium of from about 2.3 to about 12.0, andii) the soluble calcium binding capacity=0.32[soluble citrate]+0.63[soluble phosphate]+0.013[soluble protein],wherein the nutritional emulsion remains physically stable for 12 to 18 months, at a storage temperature of from 1° C. to 25° C., after formulation and packaging andwherein the nutritional emulsion has a pH from about 5.5 to about 8. 2. The nutritional emulsion of claim 1, wherein the weight ratio of the soluble calcium binding capacity to the soluble calcium is from about 3.0 to about 8.0. 3. The nutritional emulsion of claim 1, wherein the weight ratio of the soluble calcium binding capacity to the soluble calcium is from about 4.0 to about 6.5. 4. The nutritional emulsion of claim 1, wherein the soluble protein constitutes from about 50% to 100% by weight of total protein in the nutritional emulsion. 5. The nutritional emulsion of claim 1, wherein the soluble protein constitutes from about 55% to 100% by weight of total protein in the nutritional emulsion, and wherein the soluble protein includes a phosphoserine-containing protein having at least about 100 mmoles of phosphoserine per kilogram of the phosphoserine-containing protein. 6. The nutritional emulsion of claim 5, wherein the soluble protein constitutes from about 60% to about 80% by weight of total protein in the nutritional emulsion. 7. The nutritional emulsion of claim 4, wherein the soluble protein consists of at least one of sodium caseinate and whey protein concentrate. 8. The nutritional emulsion of claim 4, wherein the soluble protein constitutes from about 2% to about 15% by weight of the nutritional emulsion. 9. The nutritional emulsion of claim 1, wherein the nutritional emulsion is packaged in a hermetically sealed container and is shelf stable at a storage temperature of from 18° C. to 24° C. for 3 months to 6 months. 10. A shelf stable nutritional emulsion comprising protein, carbohydrate, fat, and from about 0.1% to about 10% of calcium HMB by weight of the nutritional emulsion, wherein the nutritional emulsion comprises less than 900 mg/L of soluble calcium in a weight ratio of the calcium HMB to the soluble calcium of from about 6:1 to about 15:1,wherein the nutritional emulsion remains physically stable for 12 to 18 months, at a storage temperature of from 1° C. to 25° C., after formulation and packaging, andwherein the nutritional emulsion has a pH from about 5.5 to about 8. 11. The nutritional emulsion of claim 10, wherein the nutritional emulsion comprises less than 700 mg/L of the soluble calcium. 12. The nutritional emulsion of claim 10, wherein the nutritional emulsion comprises from about 400 mg/L to about 700 mg/L of the soluble calcium. 13. The nutritional emulsion of claim 10, wherein the weight ratio of the calcium HMB to the soluble calcium is from about 6:1 to about 12:1. 14. The nutritional emulsion of claim 10, wherein the weight ratio of the calcium HMB to the soluble calcium is from about 6:1 to about 8:1. 15. The nutritional emulsion of claim 10, wherein the nutritional emulsion includes soluble protein in an amount of from about 50% to 100% by weight of the total protein. 16. The nutritional emulsion of claim 15, wherein the soluble protein consists of at least one of sodium caseinate and whey protein concentrate. 17. The nutritional emulsion of claim 15, wherein the nutritional emulsion includes the soluble protein in an amount of from about 55% to 100% by weight of the total protein and includes a phosphoserine-containing protein having at least about 100 mmoles of phosphoserine per kilogram of the phosphoserine-containing protein. 18. The nutritional emulsion of claim 10, wherein the nutritional emulsion includes soluble protein in an amount of from about 60% to about 85% by weight of the total protein.
Sole Michael J.,CAXITX M6B 1L3 ; Jeejeebhoy Khursheed N.,CAXITX M4V 2V5, Composition for improvement of cellular nutrition and mitochondrial energetics.
Spence Bridget A. (Houston TX) Southwick Jeffrey G. (Houston TX) Chin Steven S. (Houston TX) Hoxmeier Ronald J. (Houston TX), Low viscosity adhesive compositions containing asymmetric radial polymers.
Murdick Brian K. ; Sita Lewis H. ; Stevens Todd A. ; Stavroff Vera T., Method of manufacturing an aseptically sterilized package containing a liquid nutritional product.
Carlson Susan E. ; Ponder Debra L. ; Montalto Michael B. ; Dohnalek Margaret H. ; Benson John D. ; Borror David A. ; Diodato David V., Methods for reducing the incidence of necrotizing enterocolitis.
Brule Grard (Rennes FRX) Roger Loc (Rennes FRX) Fauquant Jacques (Monfort FRX) Piot Michel (Rennes FRX), Non-phosphorylated peptides from casein-based material.
Liebrecht Jeffery Wayne (Columbus OH) Mazer Terrence Bruce (Reynoldsburg OH) Chandler Michael Allen (Gahanna OH) Schopinsky Gerald Edward (Westerville OH) Dewille Normanella Torres (Upper Arlington O, Nutritional liquid supplement beverage and method of making same.
Robert Johan Joseph Hageman NL; Rudolf Leonardus Lodewijk Smeets NL; George Verlaan NL, Nutritional preparation comprising ribose and medical use thereof.
Normanella T. DeWille ; Jeffrey G. Morris CA; Terrence B. Mazer ; Paul S. Anloague ; Amanda L. Smeller ; Michael A. Chandler ; Diane M. Garcia ; Louis I. Ndife, Nutritionally complete low pH enteral formula.
Borschel, Marlene W.; Luebbers, Steven T.; Black, Cynthia J.; Costigan, Timothy; McKamy, Daniel L., Pediatric formula and methods for providing nutrition and improving tolerance.
Marlene W. Borschel ; Steven T. Luebbers ; Cynthia J. Black ; Daniel L. McKamy ; Timothy Costigan, Pediatric formula and methods for providing nutrition and improving tolerance.
Kyle David J. (Catonsville MD) Reeb Sue E. (Baltimore MD) Sicotte Valerie J. (Baltimore MD), Pharmaceutical composition and dietary supplement containing docosarexaenoic acid obtained from dinoflagellates.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.